Dr. Daniel Jethanamest, MD

Dr. Jethanamest practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Jethanamest's NPI, 1992849095, was assigned on February 20, 2007. Dr. Jethanamest graduated from New York University School of Medicine in 2006. Dr. Jethanamest holds New York license 252721.

Dr. Jethanamest's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Jethanamest's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Jethanamest is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Jethanamest to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jethanamest practices, 3 sites in all. Vendor and product names are available with a free account.

Otology and neurotology is Dr. Jethanamest's primary specialty in the NPI Registry, under taxonomy code 207YX0901X. Dr. Jethanamest is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Jethanamest is licensed in New York.

Dmand AI lists chronic ear infection, ear eustachian tube disorders, ear infection, hearing loss and impairment, swimmer's ear, tinnitus and vertigo among the conditions Dr. Jethanamest treats.

CMS data shows 1,220 Medicare services from Dr. Jethanamest across 9 procedure codes in 2024, for 450 Medicare patients. Medicare paid $81,916 for them. Every service was in an office.

CMS counts 450 Medicare patients who saw Dr. Jethanamest in 2024. The largest group is 65 to 74, with 195 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jethanamest's median patient age at 54, with 48% women.

In 2024, Dr. Jethanamest wrote 139 Medicare Part D claims for 83 patients. 85% of them were for generic drugs. CMS names the drug for 86 of them, across 4 drugs with 11 or more claims each, at $5,525 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Jethanamest for performance year 2024, reported as part of a group. Dr. Jethanamest accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jethanamest as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 56 papers to Dr. Jethanamest, published from 2011 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Cochlear Implants, Cochlear Implantation and Speech Perception. Dr. Jethanamest has published most often in Otol Neurotol. Dr. Jethanamest's most frequent co-authors are David R. Friedmann, MD, Sean Oleary McMenomey, MD and Emily Kay-Rivest, MD.

Dmand AI links Dr. Jethanamest to 1 clinical trial. Conditions studied include Hearing Loss, Bilateral and Hearing Loss, Sensorineural.

CMS Open Payments shows 26 general payments to Dr. Jethanamest from 4 drug and device companies in 2025. Consulting fees make up the largest share, 48% of the total. iotaMotion, Inc. paid the most, $2,571.

Dmand AI lists 1 award for Dr. Jethanamest, most recently CMS Stage 1 EHR in 2013.

Dr. Jethanamest graduated from New York University School of Medicine in 2006. Dr. Jethanamest is a member of NHS and American Neurotology Society.

Dr. Jethanamest is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.